CNCKCNCKNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank33
5Y CAGR-27.3%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
-27.3%/yr
Long-term compound
Percentile
P33
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM0.55%+116.6%
2025-3.29%-308.9%
20241.57%+873.2%
2023-0.20%-109.8%
20222.08%-22.6%
20212.69%-86.8%
202020.31%-